Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Targovax ASA: Two abstracts accepted at the SITC Congress PR Newswire OSLO, Norway, Oct. 6, 2021 OSLO, Norway, Oct. 6, 2021 /PRNewswire/...
Targovax ASA appoints Ola Melin as Head of Manufacturing PR Newswire OSLO, Norway, Sept. 30, 2021 OSLO, Norway, Sept. 30, 2021 /PRNewswire/...
Targovax granted European Patent for ONCOS-102 in combination with chemotherapy PR Newswire OSLO, Norway, Sept. 24, 2021 Patent protection of...
Targovax granted European Patent for ONCOS-102 in combination with chemotherapy Patent protection of ONCOS-102 in combination with chemotherapy...
Targovax ASA: Poster at European Society for Medical Oncology (ESMO) PR Newswire OSLO, Norway, Sept. 16, 2021 Describing the role of ONCOS-102 in...
Targovax ASA: Poster at European Society for Medical Oncology (ESMO) Describing the role of ONCOS-102 in combination with aPD1 in aPD1...
Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress PR Newswire OSLO, Norway, Aug...
Targovax ASA: second quarter and first half year 2021 results PR Newswire OSLO, Norway, Aug. 18, 2021 OSLO, Norway, Aug. 18, 2021 /PRNewswire/...
Targovax to present at upcoming scientific conferences PR Newswire OSLO, Norway, Aug. 16, 2021 OSLO, Norway, Aug. 16, 2021 /PRNewswire/ ...
Targovax ASA: Invitation to presentation of Targovax's second quarter and first half 2021 results, Wednesday 18 August PR Newswire OSLO, Norway...
Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer PR Newswire OSLO, Norway, July 1, 2021 OSLO, Norway, July 1, 2021 /PRNewswire/...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관